Upregulation/NN
of/IN
bcl-2/NN
by/IN
the/DT
Epstein-Barr/JJ
virus/NN
latent/JJ
membrane/NN
protein/NN
LMP1/NN
:/:
a/DT
B-cell-specific/JJ
response/NN
that/WDT
is/VBZ
delayed/VBN
relative/JJ
to/TO
NF-kappa/NN
B/NN
activation/NN
and/CC
to/TO
induction/NN
of/IN
cell/NN
surface/NN
markers/NNS
./.

An/DT
ability/NN
of/IN
the/DT
Epstein-Barr/JJ
virus/NN
latent/JJ
membrane/NN
protein/NN
LMP1/NN
to/TO
enhance/VB
the/DT
survival/NN
of/IN
infected/JJ
B/NN
cells/NNS
through/IN
upregulation/NN
of/IN
the/DT
bcl-2/NN
oncogene/NN
was/VBD
first/RB
suggested/VBN
by/IN
experiments/NNS
involving/VBG
gene/NN
transfection/NN
and/CC
the/DT
selection/NN
of/IN
stable/JJ
LMP1+/JJ
clones/NNS
(/(
S.Henderson/NNP
,/,
M./NNP
Rowe/NNP
,/,
C.Gregory/NNP
,/,
F.Wang/NNP
,/,
E.Kieff/NNP
,/,
and/CC
A.Rickinson/NNP
,/,
Cell/NNP
65/CD
:/:
1107-1115/CD
,/,
1991/CD
)/)
./.
=====
However/RB
,/,
it/PRP
was/VBD
not/RB
possible/JJ
to/TO
ascertain/VB
whether/IN
Bcl-2/NN
upregulation/NN
was/VBD
a/DT
specific/JJ
consequence/NN
of/IN
LMP1/NN
expression/NN
or/CC
an/DT
artifact/NN
of/IN
the/DT
selection/NN
procedure/NN
whereby/WRB
rare/JJ
Bcl-2+/JJ
cells/NNS
already/RB
present/JJ
in/IN
the/DT
starting/VBG
population/NN
might/MD
best/RBS
be/VB
able/JJ
to/TO
tolerate/VB
the/DT
potentially/RB
toxic/JJ
effects/NNS
of/IN
LMP1/NN
./.
=====
We/PRP
therefore/RB
reexamined/VBD
this/DT
issue/NN
by/IN
using/VBG
two/CD
different/JJ
experimental/JJ
approaches/NNS
that/WDT
allowed/VBD
LMP1-induced/JJ
effects/NNS
to/TO
be/VB
monitored/VBN
immediately/RB
following/VBG
expression/NN
of/IN
the/DT
viral/JJ
protein/NN
and/CC
in/IN
the/DT
absence/NN
of/IN
selective/JJ
pressures/NNS
;/:
activation/NN
of/IN
the/DT
NF-kappa/NN
B/NN
transcription/NN
factor/NN
and/CC
upregulation/NN
of/IN
the/DT
cell/NN
adhesion/NN
molecule/NN
ICAM-1/NN
were/VBD
used/VBN
as/IN
early/JJ
indices/NNS
of/IN
LMP1/NN
function/NN
./.
=====
In/IN
the/DT
first/JJ
approach/NN
,/,
stable/JJ
clones/NNS
of/IN
two/CD
B-cell/NN
lines/NNS
carrying/VBG
an/DT
LMP1/NN
gene/NN
under/IN
the/DT
control/NN
of/IN
an/DT
inducible/JJ
metallothionein/NN
promoter/NN
were/VBD
induced/VBN
to/TO
express/VB
LMP1/NN
in/IN
all/DT
cells/NNS
./.
=====
Activation/NN
of/IN
NK-kappa/NN
B/NN
and/CC
upregulation/NN
of/IN
ICAM-1/NN
occurred/VBD
within/IN
24/CD
h/NN
and/CC
were/VBD
followed/VBN
at/IN
48/CD
to/TO
72/CD
h/NN
by/IN
upregulation/NN
of/IN
Bcl-2/NN
./.
=====
In/IN
the/DT
second/JJ
approach/NN
,/,
we/PRP
tested/VBD
the/DT
generality/NN
of/IN
this/DT
phenomenon/NN
by/IN
transiently/RB
expressing/VBG
LMP1/NN
from/IN
a/DT
strong/JJ
constitutively/RB
active/JJ
promoter/NN
in/IN
a/DT
range/NN
of/IN
different/JJ
cell/NN
types/NNS
./.
=====
All/DT
six/CD
B-cell/NN
lines/NNS
tested/VBN
showed/VBD
NF-kappa/NN
B/NN
activation/NN
in/IN
response/NN
to/TO
LMP1/NN
expression/NN
,/,
and/CC
this/DT
was/VBD
followed/VBN
in/IN
five/CD
of/IN
six/CD
lines/NNS
by/IN
expression/NN
of/IN
ICAM-1/NN
and/CC
Bcl-2/NN
./.
=====
In/IN
the/DT
same/JJ
experiments/NNS
,/,
all/DT
three/CD
non-B-cell/JJ
lines/NNS
showed/VBD
NF-kappa/NN
B/NN
activation/NN
and/CC
ICAM-1/NN
upregulation/NN
but/CC
never/RB
any/DT
effect/NN
upon/IN
Bcl-2/NN
./.
=====
We/PRP
therefore/RB
conclude/VBP
that/IN
Bcl-2/NN
upregulation/NN
is/VBZ
part/NN
of/IN
the/DT
panoply/NN
of/IN
cellular/JJ
changes/NNS
induced/VBN
by/IN
LMP1/NN
but/CC
that/IN
the/DT
effect/NN
is/VBZ
cell/NN
type/NN
specific/JJ
./.
=====
Our/PRP$
data/NNS
also/RB
suggest/VBP
that/IN
whilst/IN
NF-kappa/NN
B/NN
may/MD
be/VB
an/DT
essential/JJ
component/NN
of/IN
LMP1/NN
signal/NN
transduction/NN
,/,
other/JJ
cell-specific/JJ
factors/NNS
may/MD
be/VB
required/VBN
to/TO
effect/VB
some/DT
functions/NNS
of/IN
the/DT
viral/JJ
protein/NN
./.